I, Helen Tope, nominated by, and residing in, Australia, co-chair of the Medical and Chemicals Technical Options Committee and co-chair of the Decision XXXI/3 Task Force on Unexplained Emissions of CFC-11, and member of the Technology and Economic Assessment Panel (TEAP), declare as follows.
Name: Helen Tope
Date: 1st April 2020
I, ZHANG Jianjun, nominated by China, residing in China, co-chair of the Medical Chemicals Technical Options Committee, member of the Technology and Economics Assessment Panel declare as follows:
Signed: ZHANG Jianjun
Date: 8th February 2020
I, Emmanuel Addo-Yobo, nominated by UNEP Ozone Secretariat, residing in Ghana, and a member of the Medical and Chemicals Technical Options Committee declare as follows:
Name: Professor Emmanuel Addo-Yobo
Date: 29th April 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Fatima Al-Shatti, nominated by Kuwait, residing in Kuwait, a (member/co-chair) of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Fatima Al-Shatti
Date: 30th April 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Paul J. Atkins, nominated by the United States of America and residing in the United States, a Member of the Medical and Chemicals Technical Options Committee declare as follows.
Paul J. Atkins PhD.
16th June 2020
I, William Auriemma, nominated by and residing in the United States of America, a Member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: William Auriemma
Date: May 4, 2020
I, Dr. Christian SEKOMO BIRAME, nominated by Rwanda Environmental Management Authority (REMA) / RWANDA, residing in RWANDA, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Dr. Christian SEKOMO BIRAME
Date: 30th April 2020
I, Olga Blinova, nominated by the Russian Federation, residing in the Russian Federation, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Olga Blinova
Date: April 15, 2020
I, Steve Burns, nominated by and residing in UK, a member of the Medical and Chemicals Technical Options Committee, declare as follows.
Name: Steve Burns
Date: 13rd May 2020
Signed: Nicholas J. Campbell (signed electronically by submission)
Date: 15th April, 2020
I, Richard J, Cooke, nominated by Canada, residing in Canada, a Member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Richard J. Cooke
Date: April 20, 2020
I, Maureen George, residing in the United States a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Maureen George
Date: 4/15/20
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Kathleen Hoffman, nominated by United States of America, residing in United States of America, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Kathleen Hoffman
Date: May 1, 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Jianxin Hu nominated by China, and residing in China, a Member of the Medical and Chemicals Technical Options Committee and member of the Decision XXXI/3 Task Force on Unexplained Emissions of CFC-11 declare as follows.
Name: Jianxin Hu
Date: March 14, 2020
I, Ryan Hulse nominated by USA, residing in USA, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Ryan Hulse
Date: April 30, 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Rabinder N Kaul, nominated by, and residing in India, appointed as member of the Medical and Chemicals Technical Options Committee and TEAP’s Task Force on Unexpected Emissions of CFC-11 under Decision XXXI/3 declare as follows:
Name: Rabinder N Kaul
Date: April 1, 2020
I, DR. JAVAID A. KHAN_, nominated by (add party) AGA KHAN UNIVERSITY, KARACHI, residing in (add party) _PAKISTAN_, a (Member/co-chair) of the Medical and Chemicals Technical Options Committee declare as follows.
Name: JAVAID A. KHAN
Date: April 28 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Andy Lindley, nominated by United Kingdom, residing in United Kingdom, a member of the Medical and Chemicals Technical Options Committee and the XXXI/3 CFC-11 TEAP Task Force declare as follows.
Name: Andy Lindley
Date: 18 April 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
2 Where a Member benefits from finance that has been channelled through a conduit, the Member should also identify the source of the finance.
I, Gerald McDonnell, nominated by United Kingdom, residing in United States, a Member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Dr. Gerald McDonnell
Date: April 16, 2020
I, Robert J. Meyer, MD, nominated by The United States of America, residing in the USA, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Robert J. Meyer, MD
Date: 15-Apr-2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Dr. B. Narsaiah, nominated by the Government of India, residing in India, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Dr. B. Narsaiah
Date: April 30, 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Timothy James Noakes, nominated by the United Kingdom, residing in the United Kingdom, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Timothy James Noakes
Date: 15/4/2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, John G. Owens, appointed by the Halons Technical Options Committee co-chairs as a Consulting Expert, residing in the United States of America, declare as follows:
Signed: John G. Owens
Date: 29 April 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Jose Pon, nominated by Venezuela residing in United States, a Member of the Medical and Chemicals Technical Options Committee and Co-chair of the CFC 11 Task Force declare as follows.
Name: Jose Pons
Date: 5/05/20
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Hans Porre, nominated by The Netherlands, residing in The Netherlands, a (member/co-chair) of the Medical and Chemicals Technical Options Committee declare as follows.
Name: J.G.W. Porre
Date: April 28, 2020
I, John Pritchard, nominated by and residing in United Kingdom, a Member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: JN Pritchard
Date: 15 Apr 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, Rabbur Reza, nominated by Bangladesh (A5), a member of the Medical and Chemical Technical Options Committee, declare as follows.
Name: Rabbur Reza
Date: 30th April 2020
I, Raj Sharma nominated by MTOC Chair , residing in UK a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Rajiev Sharma
Date: 01 May 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, David Sherry, residing in the United Kingdom of Great Britain and Northern Ireland, appointed as member of TEAP’s Task Force on Unexpected Emissions of CFC-11 under Decision XXXI/3, and member of the Medical and Chemicals Technical Options Committee, declare as follows.
Name: David Sherry
Date: 21 April 2020
I, Peter Sleigh, nominated by, and residing in, the United Kingdom, a member of the Medical and Chemicals Technical Options Committee and TEAP’s Task Force on Unexpected Emissions of CFC-11 under Decision XXX/3 declare as follows.
Name: Peter Sleigh
Date: 28th April 2020
I, Jørgen Vestbo, nominated by Ministry of Environment and Food of Denmark, residing in Denmark, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Jørgen Vestbo
Date: 28th April 2020
I, _Kristine Whorlow AM, nominated by _the Australian Government, residing in Melbourne, Australia, member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Kristine Whorlow
Date: March 23, 2020
I, Nee Sun CHOONG KWET YIVE, nominated by Government of Mauritius, residing in Mauritius, a Member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Nee Sun Choong Kwet Yive
Date: 29 April 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –
I, You Yizhong, nominated by China, residing in China, a Member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: You Yizhong
Date: April 15, 2020
I, ZHANG Lifei, nominated by China, residing in China, a member of the Medical and Chemicals Technical Options Committee declare as follows.
Name: ZHANG Lifei
Date: 1st April 2020
I, Hideo Mori, nominated by a consulting expert of the Medical and Chemicals Technical Options Committee declare as follows.
Name: Hideo Mori
Date: April 20, 2020
1 When making a disclosure of interest, consider the COI Guidelines as a whole, and in particular the Annex which gives the following illustrative list of interests that should be disclosed –